AI and Healthcare AI Is Changing Cancer Care and Policy
Oct 30, 2025
Debra Patt, an oncology leader and chair of ASCO's AI task force, joins Doug Flora, a community oncology expert, to dive into the transformative effects of AI in cancer care. They discuss the barriers to AI adoption, emphasizing that change management is more critical than the technology itself. The pair also tackle Medicare's AI policies, the importance of clinical decision support, and the need for diverse training data to address bias. Their insights spotlight the balance between innovation and patient safety in a rapidly evolving healthcare landscape.
AI Snips
Chapters
Books
Transcript
Episode notes
Disruption Meets Complexity In Health Care
- Health-tech disruption is driven by transparency and new entrants but has limited immediate impact in complex areas like cancer care.
- Change in pharmacy and prevention priorities signal structural shifts that could reshape patient journeys.
Change Management Is The Bottleneck
- Tools for digital health are arriving quickly but people and change management lag behind.
- Doug Flora warns adoption will fail without leaders who manage organizational change effectively.
Sustain Telemedicine Carefully
- Continue offering telemedicine when feasible because access benefits patients, but expect uncertainty in reimbursement.
- Factor payment volatility into investment decisions and prioritize flexible, low-risk deployments.
